Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres.

Background And Purpose: A variety of radiotherapy fractionations are used as potentially curative treatments for non-small cell lung cancer. In the UK, 55 Gy in 20 fractions over 4 weeks (55/20) is the most commonly used fractionation schedule, though it has not been validated in randomized phase III trials. This audit pooled together existing data from 4 UK centres to produce the largest published series for this schedule.

Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer.

Objectives: Lung cancer staging has improved in recent years. Assuming that contemporary detailed preoperative staging may yield a lower rate of stage change after surgery, we were interested to determine the impact of our lymph node dissections performed at the time of surgical resection.

Methods: We retrospectively analysed a database in our surgical unit that prospectively captured information on all patients assessed and treated for lung cancer.